论文部分内容阅读
生化药品是我国医药产品分类中的一个大类,从新中国成立之前动物脏器的提取到如今的基因工程技术产品,生化制药工业产生了巨大的变化。生化药物因对严重危害人类健康和生命的疾病具有独特治疗效果,而越来越引起人们的重视。同时,在发展的过程中,生化制药也面临着很多困难。日前,记者就此采访了生化制药工业协会常务副会长兼秘书长徐康森教授。四个阶段四大飞跃到目前为止,生化药物经历了四个阶段:1950～1978年为初具规模阶段;1978～1995年为准备发展阶段,全国年
Biochemicals are a big category in the classification of pharmaceutical products in our country. From the extraction of animal organs before the founding of new China to today’s genetically engineered products, the biochemical pharmaceutical industry has undergone tremendous changes. Biochemicals have attracted more and more attention due to their unique therapeutic effect on diseases that seriously endanger human health and life. At the same time, Biochemical Pharmaceutical also faces many difficulties in its development. Recently, this reporter interviewed Biochemical Pharmaceutical Industry Association executive vice president and secretary general Xu Kangsen professor. Four leaps in four stages So far, biochemical drugs have gone through four stages: from 1950 to 1978 to take shape for the stage; from 1978 to 1995 to prepare for the development stage, the national year